Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
1.610
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
128
Open
1.610
Bid (Size)
1.520 (2)
Ask (Size)
1.630 (11)
Prev. Close
1.610
Today's Range
1.610 - 1.610
52wk Range
0.6243 - 7.350
Shares Outstanding
12,908,520
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Applied DNA Sciences: Q2 Earnings Insights
May 11, 2023
Via
Benzinga
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
May 11, 2023
Via
ACCESSWIRE
Performance
YTD
+2.55%
+2.55%
1 Month
+55.56%
+55.56%
3 Month
+28.80%
+28.80%
6 Month
+11.03%
+11.03%
1 Year
+46.36%
+46.36%
More News
Read More
Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023
May 03, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal Regulation
April 07, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Sciences's Return On Capital Employed Insights
February 13, 2023
Via
Benzinga
Applied DNA Achieves Milestone for Large-Scale linearDNA™ Production, Delivers Largest Single Shipment by Volume to Date
March 29, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) Assay
March 22, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Announces New York State Award Valued at Up To $1.5 Million to Support Establishment of cGMP linearDNA™ Production Capacity on Long Island, New York
February 10, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Earnings Outlook For Applied DNA Sciences
December 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 09, 2023
Via
Benzinga
Applied DNA Reports First Quarter Fiscal 2023 Financial Results
February 09, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023
February 02, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
Preview: Applied DNA Sciences's Earnings
December 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 25, 2023
Via
Benzinga
Applied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based Vaccines
January 05, 2023
From
Applied DNA Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
December 26, 2022
Via
Benzinga
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
December 14, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Earnings Scheduled For December 14, 2022
December 14, 2022
Via
Benzinga
Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
December 12, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Earnings Scheduled For December 12, 2022
December 12, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 01, 2022
Via
InvestorPlace
Applied DNA to Establish North America’s First Enzymatic (Cell Free) Large-Scale cGMP DNA Manufacturing Capacity in Suffolk County, New York
October 24, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 17, 2022
Via
Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
October 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 14, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.